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While signal transducer and activator of transcription (STAT) 3
signaling has been linked to multiple pathways inﬂuencing immune
function and cell survival, the direct inﬂuence of this transcription
factor on innate immunity and tissue homeostasis during pneumo-
nia is unknown. Humanpatientswith dominant-negativemutations
in the Stat3 gene develop recurrent pneumonias, suggesting a role
forSTAT3inpulmonaryhostdefense.Wehypothesizedthatalveolar
epithelial STAT3 is activated by IL-6 family cytokines and is required
for effective responses during gram-negative bacterial pneumonia.
STAT3 phosphorylation was increased in pneumonic mouse lungs
and in murine lung epithelial (MLE)-15 cells stimulated with pneu-
monic bronchoalveolar lavage ﬂuid (BALF) through 48 hours of
Escherichia coli pneumonia. Mice lacking active STAT3 in alveolar
epithelial cells (Stat3D/D) had fewer alveolar neutrophils and more
viable bacteria than control mice early after intratracheal E. coli.B y
48 hoursafterE. coliinfection,however,lunginjurywasincreasedin
Stat3D/D mice. Bacteria were cleared from lungs of both genotypes,
albeit more slowly in Stat3D/D mice. Of the IL-6 family cytokines
measured in lungs from infected C57BL/6 mice, IL-6, oncostatin M,
leukemia inhibitory factor (LIF), and IL-11 were signiﬁcantly ele-
vated. Neutralization studies demonstrated that LIF and IL-6 medi-
atedBALF-inducedSTAT3activationinMLE-15cells.Together,these
results indicate that during E. coli pneumonia, select IL-6 family
members activate alveolar epithelial STAT3, which functions to
promote neutrophil recruitment and to limit both infection and
lung injury.
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Lung infections account for a tremendous burden of disease
worldwide and are a leading cause of acute lung injury (1, 2).
While Streptococcus pneumoniae is the most common agent in
patients with community-acquired pneumonia (3), gram-negative
rods such as Escherichia coli are a frequent cause of nosocomial
pneumonia (4). Elimination of these and other pathogens from
the lower respiratory tract is made possible by an effective
innate immune response (5), which is necessary yet potentially
dangerous to the infected host. For this reason, cytokine net-
works, neutrophil emigration, plasma extravasation, and other
characteristics of acute inﬂammation must be precisely regu-
lated to maintain tissue homeostasis.
The STAT3 transcription factor inﬂuences both immunity
and inﬂammatory injury, but the importance of STAT3 signal-
ing during pneumonia is unknown. STAT3 activity has been
attributed both inﬂammatory (6–9) and anti-inﬂammatory (10–
12) roles. Likewise, the cytokine interleukin (IL)-6, which
largely signals through STAT3 (13, 14), has also been described
as both pro- (15–19) and anti-inﬂammatory (16, 20–22), depend-
ing on the biological context. During E. coli pneumonia,
neutrophil recruitment and bacterial clearance are impaired in
IL-6–deﬁcient mice (15). While the mechanisms through which
IL-6 functions during this infection were not determined,
tyrosine 705-phosphorylated STAT3 (pSTAT3) content was
reduced in the lungs of IL-6–deﬁcient mice, suggesting that this
pathway may be required for activation of innate host defense
during gram-negative pneumonia. A role for STAT3 in pulmo-
nary host defenses is also suggested by human patients with
hyper-IgE syndrome, in which defective STAT3 activity results
in recurrent lung infections (23–25).
IL-6 is but one member of a family of cytokines bearing its
name, all of which signal through STAT3 (14). In the current
study we hypothesized that alveolar epithelial STAT3 is acti-
vated by IL-6 family cytokines and is required for host defense
and the prevention of lung injury during gram-negative pneu-
monia. We focused on alveolar epithelial cells for several
reasons: (1) STAT3 is rapidly activated in this cell type during
inﬂammatory responses to LPS (26), the major inﬂammatory
stimulus of gram-negative bacteria; (2) alveolar epithelial cells
produce cytokines and other inﬂammatory mediators required
for host defense (27, 28); (3) activated STAT3 in alveolar
epithelial cells is required to prevent lung injury in response
to hyperoxia (10) and adenovirus exposure (12); and (4) STAT3
overexpression in alveolar epithelial cells is sufﬁcient to induce
pulmonary inﬂammation (9). To address our hypothesis, we
identiﬁed factors required for alveolar epithelial STAT3 acti-
vation, and determined the outcome of bacterial pneumonia in
mice lacking functional STAT3 in alveolar epithelial cells.
MATERIALS AND METHODS
Mice
Triple transgenic mice were bred as previously described (10) to
generate colonies of control mice (SP-CrtTA2/2/(tetO)7CMV-Cretg/tg/
Stat3ﬂx/ﬂx)o rStat3D/D mice (SP-CrtTAtg/-/(tetO)7CMV-Cretg/tg/Stat3ﬂx/ﬂx),
which cannot express the Y705-phosphorylated, active form of STAT3 in
their alveolar epithelial cells. For select experiments, SP-CrtTA2/2/
CLINICAL RELEVANCE
Our results indicate that alveolar epithelial STAT3 activa-
tion requires IL-6 family cytokines and mediates inﬂam-
mation during pneumonia. This pathway is a plausible
therapeutic target for improving host defense and/or
preventing lung injury.
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(tetO)7CMV-Cretg/tg (rtTA1) mice to generate colonies containing rtTA
and Cre-recombinase mutations without a mutation in either Stat3 allele.
Results obtained from transgenic mice were compared with littermate
controls. Food for breeders contained doxycycline (625 mg/kg) to induce
Cre-recombinase–mediated STAT3 deletion. The differentiation pattern
of cells bearing surfactant protein C promoter activity during lung
development results in gene rearrangement within virtually all alveolar
epithelial cells (both types I and II) using this doxycycline regimen (29).
Progeny were not exposed to the doxycycline diet once weaned from
their mothers at 3 weeks of age, reducing the possibility that doxycycline
might be present during experiments. At the time of experimentation,
mice were 6 to 9 weeks of age. Experiments with nontransgenic mice were
performed using C57BL/6 mice. All experimental protocols were ap-
proved by the Harvard Medical Area Standing Committee on Animals.
Pneumonia
Mice were anesthetized by an intraperitoneal injection of ketamine (50
mg/kg)/xylazine (5 mg/kg). An angiocatheter was placed down the left
bronchus, and mice received intratracheal administrations of 50 ml
saline containing approximately 106 colony-forming units (CFU) E.
coli (American Type Culture Collection # 19138; ATCC, Manassas,
VA). The concentration of viable bacteria was estimated by optical
density and subsequently veriﬁed by enumerating CFU from serial
dilutions grown on 5% sheep blood agar plates. For histologic experi-
ments, the instillate contained 1% colloidal carbon to visualize pul-
monary deposition.
Lung Histology and Morphometry
After24or48hoursofinfection,micewerekilledbyhalothaneoverdose
and the heart was ligated to maintain pulmonary blood volume. Lungs
were removed and instilled with 6% gluteraldehyde at 23 cm H2O
pressure for ﬁxation. The percentage of alveolar airspace occupied by
neutrophils or edema ﬂuid was quantiﬁed by blinded morphometric
analysis on hematoxylin/eosin-stained lung sections as previously de-
scribed (30). In rare cases in which lung sections from Stat3D/D or rtTA1
mice contained areas of emphysema-like airspace enlargement, these
regions were excluded from morphometric analyses.
Bacteriology
Lungs were collected 24 and 48 hours after intratracheal E. coli,
homogenized in 10 ml sterile H2O, serially diluted, and grown over-
night at 378C on 5% sheep blood agar plates. Viable bacteria were
determined by colony counts and expressed as total CFU per lung.
Cytokine Protein Measurement
Lungs were homogenized in H2O containing the Roche Complete
protease inhibitor cocktail (Roche, Indianapolis, IN), resuspended in
lysis buffer (0.5% Triton X-100, 150 mM NaCl, 15 mM Tris-HCl, 1 mM
CaCl2, 1 mM MgCl2), and incubated on ice for 30 minutes. After the
incubation, lysates were cleared by centrifugation, and supernatants were
collected for protein analyses. Cytokine concentrations were deter-
mined using enzyme-linked immunosorbent assay according to the pro-
tocols provided by the manufacturer (R&D Systems, Minneapolis, MN).
Real-Time RT-PCR
Cytokine and S100 mRNA levels were quantiﬁed in lung tissue using
real-time RT-PCR. Left lung lobes were removed from mice at the
indicated times after i.t. E. coli and preserved in RNAlater solution
(Qiagen, Valencia, CA). Total RNA was extracted and puriﬁed using
the RNeasy Mini Kit and RNAse-free DNase set, respectively (Qia-
gen). Real-time RT-PCR was performed on 10 ng puriﬁed RNA using
the iScript One-Step RT-PCR Kit for Probes (Bio-Rad, Hercules, CA)
and the iCycler iQ Real-Time PCR detection system (Bio-Rad). The
Beacon Designer software (Premier Biosoft International, Palo Alto,
CA) was used to design primers and Taqman probes (Table 1). Probes
were modiﬁed with 6-FAM (reporter dye) and Black Hole Quencher-1
(quencher dye) at the 59 and 39 ends, respectively. Values for each
sample were normalized to the content of 18S rRNA and expressed as
the fold induction compared with uninfected mice (15).
Lung Wet:Dry Weight Ratios
Mice were killed as above 48 hours after intratracheal E. coli and
exsanguinated via the abdominal aorta. The left bronchus was ligated,
and left lung lobes were removed and weighed immediately. After
desiccation at 608C, lungs were weighed again to determine wet:dry
ratios.
Bronchoalveolar Lavage
At the indicated times after intratracheal E. coli, lungs were removed
from killed mice and tracheas were cannulated with a 20-gauge,
blunted stainless steel needle. Antibiotic-free DMEM supplemented
with 10% FBS (1 ml) was instilled and withdrawn. Bronchoalveolar
lavage ﬂuid (BALF) was then centrifuged at 300 3 g to remove cells
followed by 16,100 3 g to remove bacteria and other remaining
particulate matter. Samples were stored at 2208C until use.
Cell Culture and Immunoblots
Murine lung epithelial (MLE)-15 cells were maintained as described
previously (31). Cells were seeded in 24-well tissue culture plates
(150,000 cells/well) and incubated overnight (378C in a humidiﬁed
atmosphere containing 5% CO2), resulting in approximately 80%
conﬂuence.Whereindicated,BALFwassupplementedwithneutralizing
antibodies for IL-6, oncostatin M (OSM), and/or leukemia inhibitory
factor (LIF) (10 mg/ml each; R&D Systems) and incubated for 1 hour at
378C. Preliminary experiments were performed using recombinant
cytokines to verify antibody efﬁcacy at the selected concentrations.
The same concentrations of isotype-matched nonspeciﬁc antibody were
used for controls, such that the total immunoglobulin concentration (30
mg/ml) was equivalent in each sample. MLE-15 cells were washed once
withPBSandstimulatedfor10minuteswith300mlBALF.Attheendof
the incubation, cells were washed once with ice-cold PBS and lysed with
50 ml ice-cold lysis buffer (2% NP-40, 25 mM Tris pH 7.4, 50 mM NaCl,
0.5% Na deoxycholate, and 0.2% SDS) containing the Roche Complete
TABLE 1. PRIMER AND PROBE SEQUENCES FOR REAL-TIME RT-PCR
Gene Forward Primer Reverse Primer Taqman Probe
S100A8: CTTGTTCAGAGAATTGGACATC TGCCACACCCACTTTTATC CCATCGCAAGGAACTCCTCGAAGT
S100A9: AGGCTGTGGGAAGTAATTAAGAGG CCAGAACAAAGGCCATTGAGTAAG AGCCATGTGACTGCTGCCCAACCA
IL-6: AGTTGCCTTCTTGGGACTGATG CAGGTCTGTTGGGAGTGGTATC AACCACGGCCTTCCCTACTTCACA
OSM: CCCTATATCCGCCTCCAAAACC GACTCTGTCCAGTGTGGTGTAC CCTGACCTGAGAGCTGCCTGCACC
LIF: TCTTCCCATCACCCCTGTAAATG CTTGATCTGGTTCATGAGGTTGC CCTGTGCCATACGCCACCCATGCC
IL-11: CCCCAGACCAACCTGTGATC AGTCACAGTCGAGTCTTTAACAAC CGCACGGCCCAGTCCAAGGTCAG
CT-1: GAGGCCAAGATCCGCCAGAC TGCACGTATTCCTCCAGAAGTTG ACAACCTTGCCCGCCTCCTGACCA
CNTF: TGACTTCCATCAGGCAATACATAC TTTCAGGGACCTTCTGTTCCAG ACGCTCCAAGTTTCTGCCTTCGCC
NP: TTCAGTGACCCCGGCTTCTC GGACTGCCAGGATTCAGATAACTC AGCTCCAGCTCAGCACCCTGCCTT
CLC: TCAACGAGCCTGACTTCAATCC GTAACACAGGAGGTGACTGTACG TCTGGGTCAGCCGCAGCCTGTCAT
IL-27: CCTACCAGCTCCTTCACTCC TTAGGAATCCCAGGCTGAGC TCCTGTCTCGGGCTGTTCGGGACC
Deﬁnition of abbreviations: CLC, cardiotrophin-like cytokine; CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin-1; LIF, leukemia inhibitory factor; NP, neuropoietin;
OSM; oncostatin M.
Primer and probes were designed (listed 59–39) to amplify an 80– to 200–base pair region within the open reading frame of the following transcripts: S100A8, S100A9,
IL-6, OSM, LIF, IL-11, CT-1, CNTF, NP, CLC, and IL-11.
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minutes and then cleared by centrifugation. Protein quantiﬁcation and
immunoblots were performed on supernatants as previously described
(31, 32). Primary antibodies were directed against pSTAT3 or STAT3
irrespective of phosphorylation (Cell Signaling, Danvers, MA) and
developed with a horseradish peroxidase–conjugated anti-rabbit poly-
clonal Ab (Cell Signaling).Relative densitometricunitswere determined
usingtheImageJsoftware(NationalInstitutesofHealth,Bethesda,MD).
pSTAT3densitometricunitswerenormalizedtothatoftotalSTAT3,and
data were expressed as the percent pSTAT3 immunoreactivity obtained
from control (0 h) BALF-stimulated MLE-15 cells.
For in vivo experiments, lungs were collected from killed mice at
the indicated times after intratracheal E. coli, and left lobes were
homogenized in 1 ml ice-cold lysis buffer (see above) using a rotor-
stator homogenizer. Protein extractions and immunoblots were per-
formed as described above.
Statistics
Statistical analyses were performed using GraphPad Prizm (GraphPad
Software, SanDiego, CA)or Statistica (StatSoft,Tulsa,OK). Data were
presented as means 6 SE for the number of samples identiﬁed in each
ﬁgure. Real-time RT-PCR data were calculated as fold-induction and
thus were presented as geometric means 6 geometric SE. Comparisons
were performed with a Student’s t test, Mann-Whitney U test, or a one-
wayANOVAfollowedbyaBonferroniposthocanalysis.Whendatadid
not pass Levene’s test for homogeneity of variance they were log-
transformed to ﬁt requirements for ANOVA. Differences were consid-
ered statistically signiﬁcant when P , 0.05.
RESULTS
Lung and Alveolar Epithelial STAT3 Are Activated during
E. coli Pneumonia
pSTAT3levelsweremeasuredintotallungproteinextractionsas
a determinant of STAT3 activity. After infection of mouse lungs
with E. coli, pSTAT3 was detectable by 2 hours, peaked at
6 hours, and remained elevated through 48 hours (Figure 1A).
To determine whether an E. coli exudate was capable of ac-
tivatingSTAT3inepithelialcells,weharvestedcell/bacteria-free
BALF from pneumonic mice 0 to 72 hours after intratracheal E.
coli and stimulated the alveolar epithelial cell line MLE-15 (33)
for10minutes.pSTAT3increasedinMLE-15cellsinresponseto
pneumonic BALF compared with nonpneumonic BALF, peak-
ing with 6 hoursof infection and evidentthrough 48 hours. MLE-
15 cell pSTAT3 was not increased in response to direct E. coli
stimulation(datanotshown),suggestingthathost-derivedfactors
rather than trace amounts of bacteria were the cause of BALF-
induced STAT3 activation. Thus, alveolar lining ﬂuid contains
mediators that activate STAT3 phosphorylation during E. coli
pneumonia.
Alveolar Epithelial STAT3 Contributes to Early Inﬂammation
and Host Defense
To determine the function of alveolar epithelial STAT3 activa-
tionduringE.colipneumonia,weinstilledbacteriaintothelungsof
Stat3D/D and control mice. Stat3D/D mice express a truncated form
of STAT3 that lacks exon 21, the region encoding the tyrosine
residue (Y705) requisite for STAT3 activation, in their alveolar
epithelial cells (10).After 24 hours of E. coli pneumonia,Stat3D/D
mice had signiﬁcantly fewer emigrated neutrophils in their air-
spaces compared with control mice (Figure 2A). Circulating
neutrophil counts did not signiﬁcantly differ between control
(7.95310560.983105cells/ml)andStat3D/Dmice(6.3531056
1.11 3 105 cells/ml), and hence did not likely contribute to the
differences observed in the airspaces. Decreased neutrophil
recruitment in the lungs was associated with and perhaps a cause
Figure 1. Signal transducer and activator of transcription (STAT)3
activation during pneumonia. STAT3 activation (pSTAT3 content) was
determined in (A) lungs and (B) MLE-15 cells 0 to 72 hours after
intratracheal E. coli. C57BL/6 mice were instilled with 106 colony-
forming units (CFU) E. coli, and left lung lobes or bronchoalveolar
lavage ﬂuid (BALF) was collected at the indicated times. Representative
images are shown for pSTAT3 and total STAT3 in (A) lungs or (B) MLE-
15 cells stimulated with BALF for 10 minutes. Each lane represents
results from lung tissue or BALF collected from a single mouse.
Immunoreactive bands shown were approximately 90 kD in size. The
two rows in each panel show the same membrane labeled ﬁrst for
pSTAT3 and the second, after stripping, for total STAT3. Data were
generated with three mice at each time point.
Figure 2. Alveolar epithelial STAT3 and host defense at 24 hours. (A)
Alveolar neutrophils and (B) lung bacterial clearance were measured 24
hours after intratracheal E. coli in the presence and absence of func-
tional alveolar epithelial STAT3. Alveolar neutrophil counts (A) were
determined in control or Stat3D/D mice by morphometric analysis of
histologic lung sections. Viable lung E. coli (B) were quantiﬁed by
colony counts on 5% sheep blood agar plates. Neutrophil data are
presented as means 6 SE (n 5 9–11) of the percentage of alveolar
airspace occupied by neutrophils. Bacteriology data are expressed as
means 6 SE (n 5 5–10) of total lung CFU. *Statistically signiﬁcant
compared with control mice (P , 0.05).
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These data indicate that the inability to activate STAT3 in
alveolar epithelial cells compromised innate immune pulmonary
host defense during this early phase of pneumonia.
Expression of Multiple Inﬂammatory Mediators Is Not
Dependent on Alveolar Epithelial STAT3 Activation
SinceneutrophilemigrationwassigniﬁcantlyimpairedinStat3D/D
mice during pneumonia, we determined whether the expression
of early response cytokines and neutrophil chemoattractants is
dependent on alveolar epithelial STAT3 activation. CXC ELR1
chemokinesandS100proteinsmediateneutrophilmigration(34–
36), are expressed by alveolar epithelial cells (28, 37), and are
regulated at least in part by STAT3 (7, 38). In addition, the early
response cytokines TNF-a and IL-1b are required for maximal
pulmonary inﬂammation during E. coli pneumonia (39). The
CXC chemokines macrophage inﬂammatory protein-2 and LPS-
induced CXC chemokine (LIX) were not diminished by alveolar
epithelial STAT3deﬁciency,norwerelevelsofTNF-aandIL-1b
(Figure 3A). In fact, LIX and IL-1b levels were signiﬁcantly
increased at6 hoursinStat3D/D mice.Similarly,S100A8/9mRNA
expression was strongly induced in response to E. coli in both
Stat3D/D and control mice, with no signiﬁcant effect of genotype
(Figure3B).Therefore,neutrophilrecruitmentwasdecreasedby
the deﬁciency of STAT3 activation in alveolar epithelial cells by
a mechanism other than the induction of the inﬂammatory
mediators measured.
Alveolar Epithelial STAT3 Prevents Lung Injury
Neutrophil recruitment and bacterial counts were examined 48
hours after infection. Contrasting with the ﬁndings at 24 hours,
neutrophil recruitment was unaffected or perhaps slightly in-
creased (P 5 0.055) by epithelial STAT3 deﬁciency at this later
time point (Figure 4A). Numbers of viable E. coli remained
elevated in Stat3D/D mice 48 hours after E. coli infection (Figure
4B). While bacteria were less effectively cleared from the lungs
of Stat3D/D mice at both 24 and 48 hours, neutrophilic inﬂam-
mation was restored at the later time point.
Lung histology at 48 hours demonstrated alveolar ﬂooding
thatwasparticularlypronouncedintheStat3D/Dmice(Figures5A
and 5B). Morphometric quantiﬁcation conﬁrmed that a signiﬁ-
cantly greater amount of the alveolar airspace volume was ﬁlled
with edema ﬂuid in lungs collected from STAT3-deﬁcient mice
compared with controls at 48 hours (Figure 5C). In separate
experiments, wet:dry weight ratios were determined as an in-
dependent measure of pulmonary edema. Although the differ-
ence between genotypes was relatively modest, wet:dry ratios
were signiﬁcantly increased in Stat3D/D mice compared with con-
trols 48 hours after intratracheal E. coli (Figure 5D). While we
did not perform a formal survival study using Stat3D/D mice, only
one of ﬁve lived through 72 hours of infection in a pilot study,
whereassevenofninecontrolmicesurvived.Together,thesedata
demonstrate that STAT3 in the alveolar epithelium is required
for prevention of lung injury during E. coli pneumonia.
Since vascular endothelial growth factor (VEGF) can be
both STAT3 dependent (40) and cytoprotective in the lung (41,
42), we determined its expression in control and Stat3D/D mice
during pneumonia. Lung VEGF content was unaffected by
STAT3 deﬁciency at the time points analyzed (Figure 6), and,
therefore, does not likely contribute to the lung injury present
in Stat3D/D mice.
Changes in Host Defense and Lung Injury Are a Direct Result
of STAT3 Deﬁciency
Rearrangement of the Stat3 gene in Stat3D/D mice is mediated by
expressionofreversetetracycline-transactivator(rtTA)andCre-
recombinase in lung epithelial cells. To control for the potential
detrimental effects of these two products (43, 44), experiments
Figure 3. Alveolar epithelial STAT3 and lung inﬂam-
matory mediators. Lung ELR1 CXC chemokines, early
response cytokines, and S100 expression were quanti-
ﬁed after intratracheal E. coli in the presence and
absence of alveolar epithelial STAT3. Macrophage in-
ﬂammatory protein-2, LPS-induced CXC chemokine,
TNF-a, and IL-1b protein levels (A) were measured in
lung homogenate by enzyme-linked immunosorbent
assay 6 and 15 hours after intratracheal E. coli, and
expressed as means 6 SE pg/ml (n 5 4–8). S100A8/
9 mRNA (B) was determined by real-time RT-PCR 3 and
6 hours after intratracheal E. coli. Fold-induction values
(versus uninfected mice) are expressed as geometric
means 6 geometric SE (n 5 5–10). *Statistically
signiﬁcant compared with control mice (P , 0.05).
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or rtTA2, respectively) but lacking loxP insertions in Stat3
alleles. The rtTA1 mice expressed both rtTA and Cre-recombi-
nase, whereas rtTA2 mice expressed little (if promoter leakage)
or none of either transgene. During E. coli pneumonia, differ-
ences between rtTA2 and rtTA1 mice were not observed in
neutrophilemigration(24h;1461versus1561[vol%alveoli]),
bacterialkilling(24h;56680versus120676CFU/lung[3106]),
or lung liquid content (48 h; 4.7 6 0.1 versus 4.5 6 0.3 wet:dry
ratio). Because the expression of rtTA and Cre-recombinase
failed to impact these parameters, we conclude that the pheno-
types identiﬁed above inStat3D/D mice result speciﬁcallyfrom the
deﬁciency of STAT3 in alveolar epithelial cells rather than an
indirect response to upstream transgene expression.
Alveolar Epithelial STAT3 Is Activated by IL-6 Family
Cytokines during E. coli Pneumonia
The STAT3 signaling pathway is elicited by diverse cytokines,
including allmembersoftheIL-6family(14).Withtheexception
ofIL-6itself,whichhasbeenidentiﬁedasanecessarycomponent
of pulmonary host defense (15, 18), the expression patterns of
other IL-6 family cytokines have not been determined during
bacterial pneumonia. We measured mRNA for the known IL-6
family cytokines to identify candidate STAT3-activating cyto-
kines during E. coli pneumonia. Lungs were collected for RNA
analysis between 0 and 72 hours of infection to associate changes
in STAT3 activation (Figure 1) with changes in STAT3-signaling
cytokines. Of the cytokines analyzed, IL-6, OSM, LIF, and IL-11
mRNAswereinducedinresponsetointratrachealE.coli(Figure
7A), with no signiﬁcant changes detectable in the other ﬁve
cytokines analyzed (CT-1, CNTF, NP, CLC, and IL-27; data not
shown). IL-6 expression was highest among the four cytokines
(. 7,000-fold), followed in order by OSM (. 300-fold), LIF (.
15-fold), and IL-11 (. 5-fold). Since the kinetics of STAT3 ac-
tivation (Figure 1) correlated with cytokine mRNA induction,
these data implicate IL-6, OSM, LIF, and IL-11 as potential
mediators of lung STAT3 signaling during pneumonia.
To determine contributions of IL-6 family members to alve-
olar epithelial STAT3 activation, MLE-15 cells were stimulated
with BALF in the absence or presence of neutralizing antibodies
for IL-6, OSM, and LIF, the three most highly expressed cyto-
kines identiﬁed above. Consistent with our ﬁndings in Figure 1B,
BALF from mice exposed to E. coli for 24 hours strongly stim-
ulated STAT3 phosphorylation in MLE-15 cells (Figures 7B and
7D). Neutralization of IL-6 or OSM alone did not signiﬁcantly
affect BALF-induced STAT3 phosphorylation. LIF neutraliza-
tion signiﬁcantly diminished STAT3 activation in response to 24-
hour BALF. Antibody combinations revealed an additional con-
tribution of IL-6 but not OSM to MLE-15 cell STAT3 signaling,
such that neutralization of both LIF and IL-6 resulted in
signiﬁcantly less pSTAT3 than did LIF blockade alone. In fact,
STAT3 activation induced by 24-hour BALF was virtually
abolished by the combined inhibition of both IL-6 and LIF, with
densitometric values not signiﬁcantly different from those mea-
sured in response to 0 hours control BALF. After stimulation
with 48-hour BALF (Figures 7C and 7E), pSTAT3 levels were
Figure 4. Alveolar epithelial STAT3 and host defense at 48 hours.
Alveolar neutrophils (A) and lung bacterial clearance (B) were measured
48hoursafterintratrachealE.coliinthepresenceandabsenceofalveolar
epithelial STAT3. Alveolar neutrophil counts (A) were determined in
control or Stat3D/D mice by morphometric analysis of histologic lung
sections. Neutrophil data are presented as means 6 SE (n 5 9–11) of the
percentage of alveolar airspace occupied by neutrophils. Bacteriology
data are expressed as means 6 SE (n 5 5–10) of total lung CFU.
*Statistically signiﬁcant compared with control mice (P , 0.05).
Figure 5. Alveolar epithelial STAT3 and lung injury. Pulmo-
nary edema was examined 48 hours after intratracheal E. coli
in the presence and absence of alveolar epithelial STAT3.
Representative images are shown of pneumonic lung sec-
tions from (A) control or (B) Stat3D/D mice. Alveolar edema
was quantiﬁed by morphometric analysis of lung sections
(C) and data expressed as means 6 SE (n 5 7–8) of the
percentage of alveolar space occupied by edema ﬂuid.
Pulmonary edema was also measured and expressed as
means 6 SE (n 5 8–11) wet:dry (D). *Statistically signiﬁcant
compared with control mice (P , 0.05).
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densitometric values did not reach statistical signiﬁcance despite
consistent patterns observed over three separate experiments.
Considerable pSTAT3 immunoreactivity was detected in MLE-
15cellsafterstimulationwith48-hourBALFeveninthepresence
of all three blocking antibodies. Taken together, LIF and IL-6 in
alveolar lining ﬂuid are necessary for early alveolar epithelial
STAT3 activation. However, additional STAT3-activating cyto-
kines are important for this process at later time points.
DISCUSSION
Alveolar epithelial STAT3 was required early (24 h) for
maximal neutrophil recruitment and bacterial killing during E.
coli pneumonia. Later in the infection (48 h), STAT3 prevented
alveolar edema and lung injury. In addition, our in vitro ﬁndings
suggest that IL-6 family cytokines, particularly LIF, in alveolar
lining ﬂuid are necessary for STAT3 activation. We conclude
from these data that STAT3 activity in alveolar epithelial cells is
downstream of IL-6 family cytokine expression and functions to
both promote innate host defense and limit inﬂammatory injury
during pneumonia.
The phenotype of Stat3D/D mice at 24 hours of infection was
similar to that of IL-6–deﬁcient mice with E. coli pneumonia,
including decreased neutrophil recruitment and bacterial clear-
ance (15). IL-6 deﬁciency transiently decreased total lung
pSTAT3 content (15), and the present data demonstrate a tran-
sient role for IL-6 in activation of STAT3 in BALF-stimulated
MLE-15 cells. Together, these studies implicate alveolar epithe-
lial STAT3 as one avenue through which IL-6 promotes innate
immunity.Itislikely,however,thatIL-6signalsthroughothercell
types as well, such that deletion of STAT3 in only alveolar
epithelial cells understates the full contribution of IL-6 to innate
immunity inthelungs.Themechanisms, however,throughwhich
STAT3signalingpromotesinﬂammationatthisstageofinfection
remain unknown. STAT3 has been shown to inﬂuence the
expression of multiple inﬂammatory mediators (7, 9), yet our
current results indicate no contribution of STAT3 on the expres-
sion of CXC chemokines, early response cytokines, or S100
proteins during E. coli pneumonia. Future research will be
necessary to elucidate the factors that link IL-6 family-induced
STAT3 activity to alveolar neutrophil emigration.
At 48 hours, the deﬁciency of STAT3 in alveolar epithelial
cells resulted in exacerbated lung injury as measured by alveolar
ﬂooding and lung liquid accumulation. Although bacterial bur-
dens were increased in Stat3D/D mice compared with controls at
Figure 6. Alveolar epithelial STAT3 and vascular endothelial growth
factor (VEGF). Lung VEGF levels were determined 15, 24, and 48 hours
after intratracheal E. coli in the presence and absence of functional
alveolar epithelial STAT3. Protein concentrations were measured in
lung homogenate by enzyme-linked immunosorbent assay and
expressed as means 6 SE pg/ml (n 5 3–7).
Figure 7. IL-6familycytokinesandpneu-
monia. IL-6 family mRNA in the lungs (A)
was measured using real-time RT-PCR for
IL-6, oncostatin M (OSM), leukemia in-
hibitory factor (LIF), and IL-11 mRNA.
Pneumonic lung lobes were harvested
from C57BL/6 mice 0 to 72 hours after
intratracheal E. coli, and fold-induction
values (versus uninfected mice) are ex-
pressed as geometric means 6 geometric
SE (n 5 5–6). *Statistically signiﬁcant
effect of infection on mRNA levels for all
shown (P , 0.05). IL-6 family-dependent
STAT3activationinMLE-15cells(B–E)was
measured using immunoblots. MLE-15
cells were stimulated for 10 minutes with
BALFcollected0,24(B/D),or48hours(C/
E) after intratracheal E. coli, in the absence
and presence of neutralizing antibodies
for IL-6, OSM, and/or LIF. Representative
images from one of three separateexperi-
ments are shown for pSTAT3 and total
STAT3 immunoreactivity in MLE-15 cell
protein extracts in response to pooled
BALF collected at (A) 24 and (B) 48 hours.
Immunoreactive bands shown were ap-
proximately90 kD insize.Thetwo rowsin
panels B and C show the same membrane
labeled ﬁrst for pSTAT3 and the second,
after stripping, for total STAT3. pSTAT3
immunoreactivity was quantiﬁed by densitometry (D–E) and normalized to that of total STAT3. pSTAT3/STAT3 ratios are expressed as a percentage of
thevaluedeterminedforMLE-15cellsstimulatedwithcontrolBALF(0hBALF)andexpressedasmeans6SE(n53).*Statisticallysigniﬁcantcompared
with cells stimulated with 0 hours of BALF and isotype control IgG (P , 0.05). †Statistically signiﬁcant compared with cells stimulated with pneumonic
BALF and isotype control IgG. ‡Statistically signiﬁcant compared with cells stimulated with pneumonic BALF and anti-LIF (P , 0.05).
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resent less than 2% of the original E. coli inoculum. Therefore,
exaggerated lung injury at 48 hours likely resulted from dysregu-
latedinﬂammationorepithelialintegrityratherthanoverwhelm-
ing infection. The results at 48 hours also indicate the possibility
that STAT3 inﬂuences host defense independent of its early
contribution to neutrophil recruitment (at 24 h), since bacterial
burdens were higher in Stat3D/D mice despite normal or perhaps
increasedemigratedneutrophils.Whileneutrophilrecruitmentis
a critical determinant of bacterial clearance in the lower re-
spiratorytract,itisalsopossiblethatotherbactericidalfactorsare
downstream of STAT3 activation in the epithelium.
STAT3 activity has diverse biological consequences, but
perhaps the most consistent role is tissue protection (10, 12,
45). Many mechanisms are possible, including but by no means
limited to regulation of apoptosis (46), surfactant production
(47), VEGF expression (40), and heme oxygenase-1 expression
(48). STAT3 in alveolar epithelial cells helps prevent lung injury
after hyperoxia or adenovirus administration via mechanisms
that include the expression of surfactant protein-B and possibly
the anti-apoptotic protein Bcl-xL (10, 12). The overexpression
of a constitutively active form of STAT3 in the airway epithe-
lium protects mice from hyperoxic lung injury, in part due to
decreased expression of matrix metalloproteinases 9 and 12
(11). VEGF is also expressed in response to STAT3 activation
(40) and can be cytoprotective in the lungs (41, 42), but our
current data suggest that this growth factor was not responsible
for the phenotype observed in Stat3D/D mice. STAT3 target
genes important during pneumonia may include those identiﬁed
above as well as others. The net effects of STAT3 activity in the
alveolar epithelium of infected lungs are to increase bacterial
clearance and limit lung injury.
It was recently shown that dominant-negative mutations in
the Stat3 gene in humans result in the hyper-IgE syndrome (24,
25). Recurrent pneumonias are a hallmark of this disease, and
lung infection is either directly or indirectly the cause of death
in these patients (23). The present results establish a causal link
between STAT3 and host responses to bacteria in the lungs.
Our current data indicate that STAT3 deﬁciency in the alveolar
epithelial cells reduces both innate immune responsiveness and
tissue protection during pneumonia, which suggests that de-
fective functions in these cells may contribute to the pathogen-
esis of hyper-IgE syndrome.
Because alveolar epithelial STAT3 has such important func-
tionsduringpneumonia,wesoughttodetermineupstreamfactors
contributing to its activation. Multiple cytokines and growth
factors stimulate STAT3 signaling. We focused on IL-6 family
members due to the importance of IL-6 during pneumonia (15,
18) and the shared requisite use of the gp130/STAT signaling
pathway by this family of cytokines (49). Alveolar epithelial cells
expressgp130andareresponsivetoIL-6familycytokines(26,47,
50). Little is known about IL-6 family members other than IL-6
during pneumonia, but OSM and LIF are increased in serum and
BALF of patients with pneumonia and acute lung injury (51, 52).
We observed increased lung mRNA for IL-6, OSM, LIF, and IL-
11afterintratrachealE.coli.ThecombinedblockadeofbothIL-6
and LIF completely inhibited STAT3 phosphorylation induced
by BALF from mice infected 24 hours previously, suggesting
these two cytokines as essential to activating alveolar epithelial
STAT3earlyduringpneumonia.Despiteitscomparativelylower
level of mRNA induction, LIF was the most essential of the IL-6
familycytokinesinBALFforactivatingSTAT3phosphorylation
in MLE-15 cells, supporting a role for LIF in particular during
pneumonia.
As with STAT3, LIF has protective effects during inﬂam-
mation. Hyperoxia-induced lung injury, which is exacerbated in
the absence of alveolar epithelial STAT3 (10), is ameliorated
when LIF is overexpressed in the lungs (53). Similarly, intra-
tracheal administration of recombinant LIF protects rats from
hyperoxia-induced lung injury (54) and inhibits LPS-induced
pulmonary inﬂammation (55). The roles of endogenous LIF are
less clear. However, increased susceptibility to endotoxemia-
induced shock in LIF-deﬁcient mice again suggests a protective
effect of this IL-6 family member during inﬂammation (56). The
regulation and function of LIF in pneumonic lungs is an
important direction for future research.
Together these results indicate a critical role for STAT3 in
alveolar epithelial cells during pneumonia. Early during in-
fection, epithelial STAT3 contributes to neutrophil recruitment,
whereas later it serves a role in protection from lung injury.
During E. coli pneumonia, both IL-6 and LIF activate STAT3
phosphorylation in alveolar epithelial cells. Variation among
patients in the LIF/IL-6:STAT3 signaling pathway may inﬂu-
ence both infection and lung injury during pneumonia.
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